Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
abeotaxane (2 trials)
Hodgkin Disease (Phase 1)
Lymphoma, Non-Hodgkin (Phase 1)
Neoplasms (Phase 1)
Trials (2 total)
Trial APIs (1 total)